Spruce Biosciences Rockets Sky-High on FDA Breakthrough for Rare Kids’ Brain Therapy
Folks, buckle up because if you’re glued to the markets this morning, you’ve probably spotted Spruce Biosciences (SPRB) lighting up the board like a fireworks show on the Fourth of July. As of this writing, shares are blasting off more than 135% in pre-market trading, pushing the price toward $21 after closing yesterday around $8.80. … Read more
https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4
Skip to content